Unicancer PRODIGE 24/CCTG PA6 trial: Updated results of a multicenter international randomized phase III trial of adjuvant mFOLFIRINOX (mFFX) versus gemcitabine (gem) in patients (pts) with resected pancreatic ductal adenocarcinomas (PDAC)
ANNÉE
2021
AUTEURS
Conroy T, Hammel P, Turpin A, Belletier C, Wei A, Mitry E, Lopez A, Francois E, Artru P, Biagi J, Lecomte T, Assenat E, Faroux R, Ychou M, Bouché O, Lambert A, Monard L, Rat P, Castan F, Bachet JB
CONGRÈS/REVUE
ESMO
ÉTUDE
Localisation
LIEN PUBLICATIONS ASSOCIÉES